8-K/AThe WireRoutine
Shareholder Vote
Filed May 24, 2024 · 2y ago · Accession 0001628280-24-025241
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Vanda Pharmaceuticals Inc.
- Ticker
- VNDA
- CIK
- 1347178
- Form type
- 8-K/A
- Filing date
- May 24, 2024
- Report date
- May 17, 2024
- Document
- vnda-20240517.htm
- Size
- 211 KB